| Year |
Citation |
Score |
| 2024 |
Doan TT, Hutton DW, Wright DR, Prosser LA. Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA. Applied Health Economics and Health Policy. PMID 38253972 DOI: 10.1007/s40258-024-00872-6 |
0.473 |
|
| 2023 |
Doan TT, DeJonckheere M, Wright DR, Hutton DW, Prosser LA. Preferences and experiences of pediatricians on implementing national guidelines on universal routine screening of adolescents for major depressive disorder: A qualitative study. Comprehensive Psychiatry. 127: 152412. PMID 37717343 DOI: 10.1016/j.comppsych.2023.152412 |
0.508 |
|
| 2023 |
Kim DD, Do LA, Synnott PG, Lavelle TA, Prosser LA, Wong JB, Neumann PJ. Developing Criteria for Health Economic Quality Evaluation (CHEQUE) Tool. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. PMID 37068557 DOI: 10.1016/j.jval.2023.04.004 |
0.618 |
|
| 2020 |
Huang Z, Wagner AL, Lin M, Sun X, Zikmund-Fisher BJ, Boulton ML, Ren J, Prosser LA. Preferences for vaccination program attributes among parents of young infants in Shanghai, China. Human Vaccines & Immunotherapeutics. 1-6. PMID 31977272 DOI: 10.1080/21645515.2020.1712937 |
0.348 |
|
| 2019 |
Sun X, Wagner AL, Ji J, Huang Z, Zikmund-Fisher BJ, Boulton ML, Ren J, Prosser LA. A conjoint analysis of stated vaccine preferences in Shanghai, China. Vaccine. PMID 31822426 DOI: 10.1016/J.Vaccine.2019.11.062 |
0.341 |
|
| 2019 |
Rose AM, Grosse SD, Garcia SP, Bach J, Kleyn M, Simon NE, Prosser LA. The financial and time burden associated with phenylketonuria treatment in the United States. Molecular Genetics and Metabolism Reports. 21: 100523. PMID 31660292 DOI: 10.1016/J.Ymgmr.2019.100523 |
0.33 |
|
| 2019 |
Harvey M, Prosser LA, Rose AM, Ortega-Sanchez IR, Harpaz R. Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition. Pain. PMID 31599852 DOI: 10.1097/J.Pain.0000000000001718 |
0.376 |
|
| 2019 |
Goodman RM, Bridges CB, Kim D, Pike J, Rose A, Prosser LA, Hutton DW. Billing and payment of commercial and Medicaid health plan adult vaccination claims in Michigan since the Affordable Care Act. Vaccine. PMID 31585724 DOI: 10.1016/J.Vaccine.2019.09.042 |
0.328 |
|
| 2019 |
Lavelle TA, Messonnier M, Stokley S, Kim D, Ramakrishnan A, Gebremariam A, Simon NE, Rose AM, Prosser LA. Use of a choice survey to identify adult, adolescent and parent preferences for vaccination in the United States. Journal of Patient-Reported Outcomes. 3: 51. PMID 31359289 DOI: 10.1186/S41687-019-0135-0 |
0.647 |
|
| 2019 |
Lavelle TA, Weinstein MC, Newhouse JP, Munir K, Kuhlthau KA, Prosser LA. Parent Preferences for Health Outcomes Associated with Autism Spectrum Disorders. Pharmacoeconomics. PMID 30895565 DOI: 10.1007/S40273-019-00783-8 |
0.688 |
|
| 2019 |
Wittenberg E, James LP, Prosser LA. Spillover Effects on Caregivers' and Family Members' Utility: A Systematic Review of the Literature. Pharmacoeconomics. PMID 30887469 DOI: 10.1007/S40273-019-00768-7 |
0.317 |
|
| 2019 |
Prosser LA, Harpaz R, Rose AM, Gebremariam A, Guo A, Ortega-Sanchez IR, Zhou F, Dooling K. A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations. Annals of Internal Medicine. PMID 30776797 DOI: 10.7326/M18-2347 |
0.335 |
|
| 2019 |
Simon NJ, Richardson J, Ahmad A, Rose A, Wittenberg E, D'Cruz B, Prosser LA. Health utilities and parental quality of life effects for three rare conditions tested in newborns. Journal of Patient-Reported Outcomes. 3: 4. PMID 30671727 DOI: 10.1186/S41687-019-0093-6 |
0.344 |
|
| 2018 |
Lavelle TA, D'Cruz BN, Mohit B, Ungar WJ, Prosser LA, Tsiplova K, Vera-Llonch M, Lin PJ. Family Spillover Effects in Pediatric Cost-Utility Analyses. Applied Health Economics and Health Policy. PMID 30350218 DOI: 10.1007/S40258-018-0436-0 |
0.674 |
|
| 2018 |
Neumann PJ, Kim DD, Trikalinos TA, Sculpher MJ, Salomon JA, Prosser LA, Owens DK, Meltzer DO, Kuntz KM, Krahn M, Feeny D, Basu A, Russell LB, Siegel JE, Ganiats TG, et al. Future Directions for Cost-effectiveness Analyses in Health and Medicine. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 767-777. PMID 30248277 DOI: 10.1177/0272989X18798833 |
0.36 |
|
| 2018 |
Richardson JS, Messonnier ML, Prosser LA. Preferences for health economics presentations among vaccine policymakers and researchers. Vaccine. PMID 30236631 DOI: 10.1016/J.Vaccine.2018.08.049 |
0.34 |
|
| 2018 |
Harvey MJ, Denton BT, Prosser LA, Hutton DW. Determining the optimal strategy for the herpes zoster vaccine in adults. Vaccine. PMID 30031663 DOI: 10.1016/J.Vaccine.2018.06.059 |
0.327 |
|
| 2018 |
Sun X, Huang Z, Wagner AL, Prosser LA, Xu E, Ren J, Wang B, Yan W, Zikmund-Fisher BJ. The role of severity perceptions and beliefs in natural infections in Shanghai parents' vaccine decision-making: a qualitative study. Bmc Public Health. 18: 813. PMID 29954371 DOI: 10.1186/S12889-018-5734-9 |
0.325 |
|
| 2018 |
Huang Z, Sun X, Wagner AL, Ren J, Boulton ML, Prosser LA, Zikmund-Fisher BJ. Parent and caregiver perceptions about the safety and effectiveness of foreign and domestic vaccines in Shanghai, China. Plos One. 13: e0197437. PMID 29782508 DOI: 10.1371/Journal.Pone.0197437 |
0.324 |
|
| 2016 |
Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, Trikalinos TA, Russell LB, Siegel JE, et al. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. Jama. 316: 1093-1103. PMID 27623463 DOI: 10.1001/Jama.2016.12195 |
0.376 |
|
| 2016 |
Harvey MJ, Prosser LA, Messonnier ML, Hutton DW. Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right. Plos One. 11: e0156737. PMID 27332996 DOI: 10.1371/Journal.Pone.0156737 |
0.306 |
|
| 2016 |
Goldenberg AJ, Comeau AM, Grosse SD, Tanksley S, Prosser LA, Ojodu J, Botkin JR, Kemper AR, Green NS. Evaluating Harms in the Assessment of Net Benefit: A Framework for Newborn Screening Condition Review. Maternal and Child Health Journal. PMID 26833040 DOI: 10.1007/S10995-015-1869-9 |
0.313 |
|
| 2015 |
Nelson CP, Routh JC, Logvinenko T, Rosoklija I, Kokorowski PJ, Prosser LA, Schuster MA. Utility scores for vesicoureteral reflux and anti-reflux surgery. Journal of Pediatric Urology. PMID 25975732 DOI: 10.1016/J.Jpurol.2015.03.008 |
0.333 |
|
| 2015 |
Prosser LA, Lamarand K, Gebremariam A, Wittenberg E. Measuring family HRQoL spillover effects using direct health utility assessment. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 35: 81-93. PMID 25057048 DOI: 10.1177/0272989X14541328 |
0.337 |
|
| 2014 |
Wright DR, Prosser LA. The impact of overweight and obesity on pediatric medical expenditures. Applied Health Economics and Health Policy. 12: 139-50. PMID 24652198 DOI: 10.1007/S40258-014-0088-7 |
0.536 |
|
| 2014 |
Lavelle TA, Wittenberg E, Lamarand K, Prosser LA. Variation in the spillover effects of illness on parents, spouses, and children of the chronically ill. Applied Health Economics and Health Policy. 12: 117-24. PMID 24590611 DOI: 10.1007/S40258-014-0079-8 |
0.662 |
|
| 2014 |
Sharp AL, Prosser LA, Walton M, Blow FC, Chermack ST, Zimmerman MA, Cunningham R. Cost analysis of youth violence prevention. Pediatrics. 133: 448-53. PMID 24515518 DOI: 10.1542/Peds.2013-1615 |
0.329 |
|
| 2014 |
Lavelle TA, Weinstein MC, Newhouse JP, Munir K, Kuhlthau KA, Prosser LA. Economic burden of childhood autism spectrum disorders. Pediatrics. 133: e520-9. PMID 24515505 DOI: 10.1542/Peds.2013-0763 |
0.68 |
|
| 2014 |
Wright DR, Taveras EM, Gillman MW, Horan CM, Hohman KH, Gortmaker SL, Prosser LA. The cost of a primary care-based childhood obesity prevention intervention. Bmc Health Services Research. 14: 44. PMID 24472122 DOI: 10.1186/1472-6963-14-44 |
0.569 |
|
| 2014 |
Kemper AR, Green NS, Calonge N, Lam WK, Comeau AM, Goldenberg AJ, Ojodu J, Prosser LA, Tanksley S, Bocchini JA. Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 16: 183-7. PMID 23907646 DOI: 10.1038/Gim.2013.98 |
0.303 |
|
| 2014 |
Chang J, Freed GL, Prosser LA, Patel I, Erickson SR, Bagozzi RP, Balkrishnan R. Comparisons of health care utilization outcomes in children with asthma enrolled in private insurance plans versus medicaid. Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners. 28: 71-9. PMID 23312366 DOI: 10.1016/J.Pedhc.2012.11.001 |
0.334 |
|
| 2013 |
Ungar WJ, Prosser LA, Burnett HF. Values and evidence colliding: health technology assessment in child health. Expert Review of Pharmacoeconomics & Outcomes Research. 13: 417-419. PMID 23977967 DOI: 10.1586/14737167.2013.815420 |
0.355 |
|
| 2013 |
Prosser LA, Payne K, Rusinak D, Shi P, Messonnier M. Using a discrete choice experiment to elicit time trade-off and willingness-to-pay amounts for influenza health-related quality of life at different ages. Pharmacoeconomics. 31: 305-15. PMID 23512145 DOI: 10.1007/S40273-013-0029-6 |
0.323 |
|
| 2012 |
Song JW, Chung KC, Prosser LA. Treatment of ulnar neuropathy at the elbow: cost-utility analysis. The Journal of Hand Surgery. 37: 1617-1629.e3. PMID 22835586 DOI: 10.1016/J.Jhsa.2012.05.012 |
0.32 |
|
| 2012 |
Prosser LA. Comparative effectiveness and child health. Pharmacoeconomics. 30: 637-45. PMID 22788256 DOI: 10.2165/11633830-000000000-00000 |
0.352 |
|
| 2012 |
Dempsey AF, Pangborn HM, Prosser LA. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus. Vaccine. 30: 4060-6. PMID 22525796 DOI: 10.1016/J.Vaccine.2012.04.011 |
0.309 |
|
| 2012 |
Prosser LA, Grosse SD, Kemper AR, Tarini BA, Perrin JM. Decision analysis, economic evaluation, and newborn screening: challenges and opportunities. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 22481131 DOI: 10.1097/01.Ogx.0000425640.65370.9F |
0.307 |
|
| 2012 |
Gidengil C, Lieu TA, Payne K, Rusinak D, Messonnier M, Prosser LA. Parental and societal values for the risks and benefits of childhood combination vaccines. Vaccine. 30: 3445-52. PMID 22449423 DOI: 10.1016/J.Vaccine.2012.03.022 |
0.319 |
|
| 2012 |
Kimmel AD, Daniels N, Betancourt TS, Wood R, Prosser LA. Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: a qualitative assessment. Aids Care. 24: 778-92. PMID 22304657 DOI: 10.1080/09540121.2011.630366 |
0.654 |
|
| 2012 |
Rhodes ET, Goran MI, Lieu TA, Lustig RH, Prosser LA, Songer TJ, Weigensberg MJ, Weinstock RS, Gonzalez T, Rawluk K, Zoghbi RM, Ludwig DS, Laffel LM. Health-related quality of life in adolescents with or at risk for type 2 diabetes mellitus. The Journal of Pediatrics. 160: 911-7. PMID 22217471 DOI: 10.1016/J.Jpeds.2011.11.026 |
0.308 |
|
| 2012 |
Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations. Drugs. 72: 35-48. PMID 22191794 DOI: 10.2165/11597310-000000000-00000 |
0.373 |
|
| 2012 |
Lavelle TA, Uyeki TM, Prosser LA. Cost-effectiveness of oseltamivir treatment for children with uncomplicated seasonal influenza. The Journal of Pediatrics. 160: 67-73.e6. PMID 21917267 DOI: 10.1016/J.Jpeds.2011.07.001 |
0.663 |
|
| 2011 |
Lavelle TA, Meltzer MI, Gebremariam A, Lamarand K, Fiore AE, Prosser LA. Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events. Plos One. 6: e27777. PMID 22205927 DOI: 10.1371/Journal.Pone.0027777 |
0.649 |
|
| 2011 |
Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. Plos One. 6: e22308. PMID 21829456 DOI: 10.1371/Journal.Pone.0022308 |
0.663 |
|
| 2011 |
Wittenberg E, Prosser LA. Ordering errors, objections and invariance in utility survey responses: a framework for understanding who, why and what to do. Applied Health Economics and Health Policy. 9: 225-41. PMID 21682351 DOI: 10.2165/11590480-000000000-00000 |
0.308 |
|
| 2011 |
Belfort MB, Zupancic JAF, Riera KM, Turner JHG, Prosser LA. Health state preferences associated with weight status in children and adolescents Bmc Pediatrics. 11. PMID 21299875 DOI: 10.1186/1471-2431-11-12 |
0.332 |
|
| 2011 |
Prosser LA, Payne K, Rusinak D, Shi P, Uyeki T, Messonnier M. Valuing health across the lifespan: health state preferences for seasonal influenza illnesses in patients of different ages. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 135-43. PMID 21211495 DOI: 10.1016/J.Jval.2010.10.026 |
0.319 |
|
| 2011 |
Prosser LA, Meltzer MI, Fiore A, Epperson S, Bridges CB, Hinrichsen V, Lieu TA. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years. Archives of Pediatrics & Adolescent Medicine. 165: 112-8. PMID 20921341 DOI: 10.1001/Archpediatrics.2010.182 |
0.36 |
|
| 2010 |
Grosse SD, Prosser LA, Asakawa K, Feeny D. QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique. Expert Review of Pharmacoeconomics & Outcomes Research. 10: 293-308. PMID 20545594 DOI: 10.1586/Erp.10.24 |
0.337 |
|
| 2010 |
Perrin JM, Knapp AA, Browning MF, Comeau AM, Green NS, Lipstein EA, Metterville DR, Prosser L, Queally D, Kemper AR. An evidence development process for newborn screening. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 12: 131-4. PMID 20154629 DOI: 10.1097/Gim.0B013E3181D28Eb1 |
0.32 |
|
| 2010 |
Prosser LA, Kong CY, Rusinak D, Waisbren SL. Projected costs, risks, and benefits of expanded newborn screening for MCADD. Pediatrics. 125: e286-94. PMID 20123779 DOI: 10.1542/Peds.2009-0605 |
0.304 |
|
| 2010 |
Gatwood J, Meltzer M, Messonnier M, Prosser L. PIN25 SEASONAL INFLUENZA VACCINATION OF HEALTHY, WORKING-AGE ADULTS: A SYSTEMATIC REVIEW OF ECONOMIC INVESTIGATIONS Value in Health. 13: A434. DOI: 10.1016/S1098-3015(11)72824-8 |
0.31 |
|
| 2010 |
Prosser L, Lavelle T, Fiore A, Bridges C, Reed C, Jain S, Dunham K, Meltzer M. PIN32 COST-EFFECTIVENESS OF 2009 PANDEMIC INFLUENZA A(H I N I) VACCINATION IN THE UNITED STATES Value in Health. 13: A192. DOI: 10.1016/S1098-3015(10)72939-9 |
0.337 |
|
| 2009 |
Lieu TA, Ray GT, Ortega-Sanchez IR, Kleinman K, Rusinak D, Prosser LA. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster. Pharmacoeconomics. 27: 1005-16. PMID 19908925 DOI: 10.2165/11314000-000000000-00000 |
0.342 |
|
| 2009 |
Wright DR, Wittenberg E, Swan JS, Miksad RA, Prosser LA. Methods for measuring temporary health States for cost-utility analyses. Pharmacoeconomics. 27: 713-23. PMID 19757865 DOI: 10.2165/11317060-000000000-00000 |
0.584 |
|
| 2009 |
O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA. New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics. 123: 1452-63. PMID 19482754 DOI: 10.1542/Peds.2008-1482 |
0.353 |
|
| 2008 |
Lieu TA, Ortega-Sanchez I, Ray GT, Rusinak D, Yih WK, Choo PW, Shui I, Kleinman K, Harpaz R, Prosser LA. Community and patient values for preventing herpes zoster. Pharmacoeconomics. 26: 235-49. PMID 18282017 DOI: 10.2165/00019053-200826030-00006 |
0.332 |
|
| 2008 |
Prosser LA, O'Brien MA, Molinari NA, Hohman KH, Nichol KL, Messonnier ML, Lieu TA. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmacoeconomics. 26: 163-78. PMID 18198935 DOI: 10.2165/00019053-200826020-00006 |
0.372 |
|
| 2008 |
Ortega-Sanchez IR, Lee GM, Jacobs RJ, Prosser LA, Molinari NA, Zhang X, Baine WB, McCauley MM, Miller T. Projected cost-effectiveness of new vaccines for adolescents in the United States. Pediatrics. 121: S63-78. PMID 18174323 DOI: 10.1542/Peds.2007-1115H |
0.345 |
|
| 2008 |
Wright D, Wittenberg E, Swan J, Miksad R, Prosser L. PMC30 A REVIEW AND CRITIQUE OF METHODS FOR MEASURING TEMPORARY HEALTH STATES IN COST-UTILITY ANALYSES Value in Health. 11: A177-A178. DOI: 10.1016/S1098-3015(10)70564-7 |
0.349 |
|
| 2008 |
Lavelle T, Uyeki T, Prosser L. PIN18 THE IMPACT OF PEDIATRIC ADVERSE EVENTS ON THE COST-EFFECTIVENESS OF OSELTAMIVIR Value in Health. 11: A97. DOI: 10.1016/S1098-3015(10)70316-8 |
0.317 |
|
| 2007 |
Ladapo JA, Neumann PJ, Keren R, Prosser LA. Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US. Pharmacoeconomics. 25: 817-28. PMID 17887804 DOI: 10.2165/00019053-200725100-00002 |
0.356 |
|
| 2007 |
Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations. Pharmacoeconomics. 25: 713-26. PMID 17803331 DOI: 10.2165/00019053-200725090-00001 |
0.39 |
|
| 2007 |
Prosser LA, Corso PS. Measuring health-related quality of life for child maltreatment: a systematic literature review. Health and Quality of Life Outcomes. 5: 42. PMID 17634122 DOI: 10.1186/1477-7525-5-42 |
0.309 |
|
| 2007 |
Simon SR, Rodriguez HP, Majumdar SR, Kleinman K, Warner C, Salem-Schatz S, Miroshnik I, Soumerai SB, Prosser LA. Economic analysis of a randomized trial of academic detailing interventions to improve use of antihypertensive medications. Journal of Clinical Hypertension (Greenwich, Conn.). 9: 15-20. PMID 17215654 DOI: 10.1111/J.1524-6175.2006.05684.X |
0.324 |
|
| 2007 |
Prosser L, Hammitt J, Keren R. PR4 VALUING CHILDREN'S HEALTH FOR ECONOMIC EVALUATIONS:THEORETICAL AND METHODOLOGICAL CONSIDERATIONS Value in Health. 10: A16. DOI: 10.1016/S1098-3015(10)68581-6 |
0.31 |
|
| 2006 |
Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NA, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerging Infectious Diseases. 12: 1548-58. PMID 17176570 DOI: 10.3201/Eid1210.051015 |
0.367 |
|
| 2005 |
Prosser LA, Bridges CB, Uyeki TM, Rêgo VH, Ray GT, Meltzer MI, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health and Quality of Life Outcomes. 3: 18. PMID 15780143 DOI: 10.1186/1477-7525-3-18 |
0.373 |
|
| 2004 |
Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 7: 554-68. PMID 15367251 DOI: 10.1111/J.1524-4733.2004.75007.X |
0.439 |
|
| 2004 |
Prosser LA, Ray GT, O'Brien M, Kleinman K, Santoli J, Lieu TA. Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics. 113: 283-90. PMID 14754939 DOI: 10.1542/Peds.113.2.283 |
0.351 |
|
| 2003 |
Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. Patient and community preferences for treatments and health states in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 9: 311-9. PMID 12814182 DOI: 10.1191/1352458503Ms903Oa |
0.473 |
|
| 2003 |
Wang SJ, Middleton B, Prosser LA, Bardon CG, Spurr CD, Carchidi PJ, Kittler AF, Goldszer RC, Fairchild DG, Sussman AJ, Kuperman GJ, Bates DW. A cost-benefit analysis of electronic medical records in primary care. The American Journal of Medicine. 114: 397-403. PMID 12714130 DOI: 10.1016/S0002-9343(03)00057-3 |
0.315 |
|
| 2002 |
Lieu TA, Thompson KM, Prosser LA, O'Brien MA, Yusuf HR, Shefer AM, Weinstein MC, Rickert DL. Emerging issues in vaccine economics: perspectives from the USA. Expert Review of Vaccines. 1: 433-42. PMID 12901581 DOI: 10.1586/14760584.1.4.433 |
0.524 |
|
| 2002 |
Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosis. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 22: 506-13. PMID 12458981 DOI: 10.1177/0272989X02238299 |
0.437 |
|
| 2002 |
Prosser L, O’Brien M, Ray G, Santoli J, Lieu T. PIN15 PREFERENCES AND WILLINGNESS-TO-PAY FOR HEALTH STATES PREVENTED BY PNEUMOCOCCAL CONJUGATE VACCINE Value in Health. 5: 262. DOI: 10.1016/S1098-3015(10)61150-3 |
0.347 |
|
| 2001 |
Clark C.M. J, Prosser LA, Stinnett AA, Goldman L, Weinstein MC. Cost-effectiveness analyses [3] (multiple letters) Annals of Internal Medicine. 135: 382-383. PMID 11529708 |
0.435 |
|
| 2001 |
Prosser LA, Stinnett AA, Goldman L, Weinstein MC. Cost-Effectiveness Analyses Annals of Internal Medicine. 135: 382. DOI: 10.7326/0003-4819-135-5-200109040-00022 |
0.499 |
|
| 2000 |
Prosser LA, Koplan JP, Neumann PJ, Weinstein MC. Barriers to using cost-effectiveness analysis in managed care decision making. The American Journal of Managed Care. 6: 173-9. PMID 10977418 |
0.45 |
|
| 2000 |
Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Annals of Internal Medicine. 132: 769-79. PMID 10819699 DOI: 10.7326/0003-4819-132-10-200005160-00002 |
0.457 |
|
| Show low-probability matches. |